BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2161458)

  • 1. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma x glioma cell line.
    Peers C; Lang B; Newsom-Davis J; Wray DW
    J Physiol; 1990 Feb; 421():293-308. PubMed ID: 2161458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of calcium currents and exocytosis by Lambert-Eaton syndrome antibodies in human lung cancer cells.
    Viglione MP; O'Shaughnessy TJ; Kim YI
    J Physiol; 1995 Oct; 488 ( Pt 2)(Pt 2):303-17. PubMed ID: 8568672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive transfer of Lambert-Eaton myasthenic syndrome induces dihydropyridine sensitivity of ICa in mouse motor nerve terminals.
    Xu YF; Hewett SJ; Atchison WD
    J Neurophysiol; 1998 Sep; 80(3):1056-69. PubMed ID: 9744921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of non-L-, non-N-type (Q-like) Ca2+ channels by Lambert-Eaton myasthenic syndrome (LEMS) antibodies in rat insulinoma RINm5F cells.
    Magnelli V; Grassi C; Parlatore E; Sher E; Carbone E
    FEBS Lett; 1996 May; 387(1):47-52. PubMed ID: 8654565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.
    Flink MT; Atchison WD
    J Bioenerg Biomembr; 2003 Dec; 35(6):697-718. PubMed ID: 15000529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
    Lang B; Pinto A; Giovannini F; Newsom-Davis J; Vincent A
    Ann N Y Acad Sci; 2003 Sep; 998():187-95. PubMed ID: 14592874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
    Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
    Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels.
    Spillane J; Ermolyuk Y; Cano-Jaimez M; Lang B; Vincent A; Volynski KE; Kullmann DM
    Neurology; 2015 Feb; 84(6):575-9. PubMed ID: 25589670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.
    Engisch KL; Rich MM; Cook N; Nowycky MC
    J Neurosci; 1999 May; 19(9):3384-95. PubMed ID: 10212298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricle.
    Lang B; Newsom-Davis J; Wray DW
    Proc R Soc Lond B Biol Sci; 1988 Oct; 235(1278):103-10. PubMed ID: 2907138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of low- and high-threshold Ca2+ channels of human neuroblastoma IMR32 cells by Lambert-Eaton myasthenic syndrome (LEMS) IgGs.
    Grassi C; Magnelli V; Carabelli V; Sher E; Carbone E
    Neurosci Lett; 1994 Nov; 181(1-2):50-6. PubMed ID: 7898770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
    Pinto A; Iwasa K; Newland C; Newsom-Davis J; Lang B
    Muscle Nerve; 2002 May; 25(5):715-724. PubMed ID: 11994966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of synaptosomal calcium channel function by Lambert-Eaton myasthenic immunoglobulin is serum-dependent.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):317-23. PubMed ID: 1363288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
    Johnston I; Lang B; Leys K; Newsom-Davis J
    Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.
    Flink MT; Atchison WD
    J Physiol; 2002 Sep; 543(Pt 2):567-76. PubMed ID: 12205190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
    Waterman SA; Lang B; Newsom-Davis J
    Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voltage-dependent sodium channels in human small-cell lung cancer cells: role in action potentials and inhibition by Lambert-Eaton syndrome IgG.
    Blandino JK; Viglione MP; Bradley WA; Oie HK; Kim YI
    J Membr Biol; 1995 Jan; 143(2):153-63. PubMed ID: 7731034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction.
    Peers C; Johnston I; Lang B; Wray D
    Neurosci Lett; 1993 Apr; 153(1):45-8. PubMed ID: 8390031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse.
    Lang B; Newsom-Davis J; Peers C; Prior C; Wray DW
    J Physiol; 1987 Sep; 390():257-70. PubMed ID: 2450991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.